查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820167

免疫組織化學市場報告（按產品（抗體、設備、試劑、試劑盒）、應用（診斷、藥物檢測）、最終用途（醫院和診斷實驗室、研究機構等）和地區分類，2025 年至 2033 年）

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球免疫組織化學市場規模達28億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到50億美元，2025-2033年期間的複合年成長率（CAGR）為6.5%。慢性病盛行率的上升、個人化醫療需求的不斷成長、診斷技術的顯著進步、醫療基礎設施投資的不斷增加以及人口老化加劇是推動市場成長的主要因素。

免疫組織化學市場分析：

  • 主要市場促進因素：傳染病和慢性病發病率的不斷上升，對先進診斷解決方案的需求日益成長，這是市場的主要促進因素。個人化醫療的廣泛應用，在很大程度上依賴生物標記識別，進一步刺激了對免疫組織化學的需求。診斷技術的重大進步提高了免疫組織化學檢測的準確性和效率。
  • 主要市場趨勢：先進成像技術的日益整合和自動化，提升了診斷通量和準確性，這是市場的主要趨勢之一。伴隨診斷和精準醫療的興起，強調了個人化治療策略。多重檢測技術的不斷發展，使得同時檢測多個生物標記成為可能，從而提高了效率。
  • 地理趨勢：北美是免疫組織化學市場最大的地區。加拿大和美國高度重視癌症研究和診斷技術的進步，推動了市場的成長。這主要得益於其雄厚的醫療保健支出和完善的醫療基礎設施。個人化醫療和基於生物標記的檢測（尤其是在腫瘤學領域）的廣泛應用，正在推動整個地區的市場成長。
  • 競爭格局：免疫組織化學行業的一些主要市場參與者包括 Abcam plc、Agilent Technologies Inc.、Beckman Coulter Inc.（Danaher Corporation）、Becton Dickinson and Company、Bio SB Inc.、Bio-Rad Laboratories Inc.、Bio-Techne Corporation、Cell Signaling Technology Inc.、F. Hoff Hr.A. Fisher、Mr. Fisher Inc.）、Mr. Hr. Fisher.
  • 挑戰與機會：市場面臨各種挑戰，包括先進成像系統和試劑的高成本、缺乏能夠解讀複雜免疫組化資料的熟練專業人員，以及嚴格的產品核准監管要求。然而，市場也面臨著許多機會，例如對個人化醫療和標靶治療的需求日益成長，這些治療方案高度依賴免疫組化標記物來制定有效的治療方案。

免疫組織化學市場趨勢：

慢性病盛行率不斷上升

包括癌症在內的慢性疾病發生率不斷上升，推動了對精準診斷和預後工具的需求。免疫組織化學技術對於檢測癌症和其他疾病的生物標記至關重要，有助於精準診斷和製定治療方案。根據世界衛生組織 (WHO) 發布的資料顯示，2022 年全球新增癌症病例約 2,000 萬例，死亡人數約 970 萬人。癌症確診後 5 年內存活的人數估計為 5,350 萬人。大約五分之一的人一生中會罹患癌症，大約九分之一的男性和十二分之一的女性死於癌症。各大主要參與者透過推出更有效的產品和服務，恰如其分地應對了這項激增的需求。例如，2024 年 4 月，生命科學研究和臨床診斷產品的全球領導者伯樂生命醫學有限公司 (Bio-Rad Laboratories, Inc.) 宣布推出首款超靈敏多重數位 PCR 檢測試劑盒 ddPLEX ESR1 突變檢測試劑盒。此檢測方法擴展了該公司針對腫瘤學市場的微滴式數位PCR (ddPCR) 產品線。該技術高度靈敏且多重突變檢測方法有助於轉化研究、療法選擇和疾病監測。預計這將進一步提升未來幾年免疫組織化學市場的預測。

重大技術進步

顯微鏡、染色技術和數位成像領域的技術創新日益增強，提高了免疫組織化學檢測程序的有效性和效率，使其成為詳細組織分析的首選方法。例如，2023年5月，全球領先的醫療技術公司BD（碧迪公司）宣佈在全球推出一款新型細胞分選儀，該儀器提供兩項突破性技術，使研究人員能夠發現傳統流式細胞術實驗中無法獲取的更詳細的細胞分選資訊。借助BD CellView影像技術，研究人員可以查看單一細胞的詳細顯微影像，並根據視覺特徵進行高速分選，從而即時確認結果。透過BD SpectalFX技術，研究人員可以實現全光譜細胞分選，並結合全新模組化光學架構和系統感知演算法帶來的擴展性能，在簡化的工作流程中執行高參數實驗。

個人化醫療日益受到關注

個人化醫療的日益普及，尤其是在腫瘤學領域，推動了對免疫組織化學的需求，以識別特定的分子標靶並根據患者的個別情況制定治療方案，從而改善治療效果。例如，2023 年 6 月，全球服務科學領導者賽默飛世爾科技宣布推出 Gibco OncoPro 腫瘤類細胞培養基試劑盒，這是第一種專門為擴增來自多種癌症適應症的患者來源的腫瘤類細胞或癌症類器官而開發的商用培養基。同樣，2023 年 1 月，班加羅爾阿波羅癌症中心推出了印度首個 AI 精準腫瘤中心 (POC)，這項重大舉措將大幅提高腫瘤治療的品質。該中心將幫助腫瘤學家、患者和照護者在規定時間內獲得最佳結果，並利用 AI 提供的巨大可能性。這正在影響全球免疫組織化學市場的收入。

免疫組織化學市場細分：

按產品分類：

  • 抗體
    • 一抗
    • 二抗
  • 裝置
    • 玻片染色系統
    • 組織微陣列
    • 組織處理系統
    • 幻燈片掃描儀
    • 其他
  • 試劑
    • 組織學染色
    • 封閉血清和試劑
    • 顯色底物
    • 固定試劑
    • 穩定劑
    • 有機溶劑
    • 蛋白水解酶
    • 稀釋劑
  • 套件

抗體佔大部分市場佔有率

疾病診斷和研究需求日益成長，尤其是癌症和傳染病，提升了對特異性抗體的需求。抗體工程領域的不斷創新提高了特異性和靈敏度，提高了診斷的準確性。不斷擴展的生物醫學研究需要多樣化的抗體來進行詳細的細胞和分子研究。個人化治療方法需要精確的生物標記識別，這促進了標靶抗體的使用。例如，2023年8月，再生元製藥公司宣布，美國生物醫學高級研究與開發管理局（BARDA）已與再生元達成協議，支持其用於預防SARS-CoV-2感染的下一代COVID-19單株抗體療法的臨床開發、臨床生產和監管許可流程。

按應用分類：

  • 診斷
    • 癌症
    • 傳染病
    • 心血管疾病
    • 自體免疫疾病
    • 糖尿病
    • 腎臟疾病
  • 藥物檢測

診斷佔產業最大佔有率

心血管疾病、傳染病、癌症、自體免疫疾病、腎臟病和糖尿病病例的不斷增加，對先進的診斷方法提出了更高的要求。同時，基於免疫組織化學檢測的特定生物標記的個人化治療方案也日益受到重視。染色技術的顯著改進和新興技術的出現提高了疾病診斷的準確性和效率。日益成長的研究活動需要詳細的細胞分析，這促進了免疫組織化學在疾病機制和病理學理解中的應用。這進一步推動了免疫組織化學市場對診斷產品的需求成長。

依最終用途分類：

  • 醫院和診斷實驗室
  • 研究機構
  • 其他

醫院和診斷實驗室是領先的細分市場

慢性病（尤其是癌症）發生率的上升，推動了對免疫組織化學等精準診斷工具的需求，這些工具旨在準確識別和分類疾病狀態。數位成像系統和染色技術的重大創新提升了免疫組織化學的診斷能力和通量，使其在臨床應用中更具吸引力。診斷流程中對高品質和監管標準的日益重視，使得像免疫組織化學這樣可靠的技術成為必要。醫療基礎設施和診斷服務投資的不斷增加，推動了已開發市場和新興市場對免疫組織化學等先進診斷方法的採用。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大的免疫組織化學市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是免疫組織化學最大的區域市場。

癌症和其他慢性病病例的增加推動了對免疫組織化學等精確診斷方法的需求，以識別有效治療的生物標記物，這正在影響整個地區的市場成長。完善的醫療設施和雄厚的研發資金正在促進先進診斷技術的採用。根據美國國家醫學圖書館的資料，預計到 2024 年，美國將新增 2,001,140 例癌症病例，並有 611,720 例癌症死亡病例。到 2021 年，癌症死亡率持續下降，自 1991 年以來避免了 400 多萬人死亡，這得益於吸煙率的下降、某些癌症的早期發現以及輔助和轉移性治療方案的改進。

（請注意，這只是關鍵參與者的部分名單，完整名單將在報告中提供。）

  • 市場競爭激烈，安捷倫科技、賽默飛世爾科技和羅氏診斷等主要參與者佔據主導地位。這些公司專注於創新和策略合作，以增強其產品組合。其他重要公司，例如默克集團、Bio-Rad Laboratories 和丹納赫集團，則強調透過合作和收購擴大其全球影響力。 2023 年 2 月，安捷倫科技公司推出了一款整合解決方案，將其 xCELLigence RTCA HT 平台與 Bio Tek BioSpa 8 自動培養箱結合。這項新開發成果提供了更高水準的工作流程自動化，從而可以進一步創建用於免疫腫瘤學的無標記高通量效力檢測，以及用於疫苗市場的高通量病毒細胞病變效應 (CPE) 檢測。

本報告回答的關鍵問題：

  • 全球免疫組織化學市場迄今表現如何，未來幾年將如何表現？
  • 全球免疫組織化學市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球免疫組織化學市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表了最具吸引力的免疫組織化學市場？
  • 根據產品，市場是如何分類的？
  • 免疫組織化學市場上最有吸引力的產品是什麼？
  • 根據應用，市場是如何分類的？
  • 免疫組織化學市場中最具吸引力的應用是什麼？
  • 根據最終用途，市場是如何分類的？
  • 免疫組織化學市場中最具吸引力的最終用途是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球免疫組織化學市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 全球免疫組織化學市場迄今表現如何，未來幾年將如何表現？
  • 全球免疫組織化學市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球免疫組織化學市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表了最具吸引力的免疫組織化學市場？
  • 根據產品，市場是如何分類的？
  • 免疫組織化學市場上最有吸引力的產品是什麼？
  • 根據應用，市場是如何分類的？
  • 免疫組織化學市場中最具吸引力的應用是什麼？
  • 根據最終用途，市場是如何分類的？
  • 免疫組織化學市場中最具吸引力的最終用途是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球免疫組織化學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球免疫組織化學市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 抗體
    • 關鍵部分
      • 一抗
      • 二抗
  • 裝置
    • 關鍵部分
      • 玻片染色系統
      • 組織微陣列
      • 組織處理系統
      • 幻燈片掃描儀
      • 其他
  • 試劑
    • 關鍵部分
      • 組織學染色
      • 封閉血清和試劑
      • 顯色底物
      • 固定試劑
      • 穩定劑
      • 有機溶劑
      • 蛋白水解酶
      • 稀釋劑
  • 套件

第7章：市場區隔：依應用

  • 診斷
    • 關鍵部分
      • 癌症
      • 傳染病
      • 心血管疾病
      • 自體免疫疾病
      • 糖尿病
      • 腎臟疾病
  • 藥物檢測

第 8 章：市場區隔：最終用途別

  • 醫院和診斷實驗室
  • 研究機構
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4404

The global immunohistochemistry market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.5% during 2025-2033. The rising prevalence of chronic diseases, the increasing demand for personalized medicines, significant advancements in diagnostic techniques, growing investments in healthcare infrastructure, and the rising aging population are some of the major factors propelling the growth of the market.

Immunohistochemistry Market Analysis:

  • Major Market Drivers: The growing incidence of infectious and chronic diseases which necessitate advanced diagnostic solutions represent the major drivers of the market. The widespread adoption of personalized medicine, which relies heavily on biomarker identification is further stimulating the demand for immunohistochemistry. Significant technological advancements in diagnostic techniques enhance the accuracy and efficiency of immunohistochemistry tests.
  • Key Market Trends: The increasing integration and automation of advanced imaging technologies to enhance diagnostic throughput and accuracy represents one of the key trends in the market. The rising shift toward companion diagnostic and precision medicine, emphasizes personalized treatment strategies. The growing development of multiplex assays allows simultaneous detection of multiple biomarkers thus increasing efficiency.
  • Geographical Trends: North America accounts for the largest region in the immunohistochemistry market. The strong emphasis on cancer research and diagnostic advancements in Canada and the US is driving the market growth. This is primarily due to the substantial healthcare spending and well-established medical infrastructure. The widespread adoption of personalized medicine and biomarker-based testing, particularly in oncology is fueling the market growth across the region.
  • Competitive Landscape: Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges in the market including high costs associated with advanced imaging systems and reagents, a lack of skilled professionals capable of interpreting complex immunohistochemical data, and strict regulatory requirements for product approvals. However, the market faces several opportunities such as the rising demand for personalized medicine and targeted therapies that rely heavily on immunohistochemical markers for effective treatment planning.

Immunohistochemistry Market Trends:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases including cancer is driving the demand for accurate diagnostic and prognostic tools. Immunohistochemistry is crucial for detecting biomarkers in cancer and other diseases, thus aiding in precise diagnosis and treatment planning. According to data published by the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, and approximately 1 in 9 men and 1 in 12 women die from the disease. This surge is aptly met by the key players by introducing more effective products and services. For instance, in April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company's Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This is further expected to boost the immunohistochemistry market forecast over the coming years.

Significant Technological Advancement

The growing technological innovations in microscopy, staining techniques, and digital imaging enhance the effectiveness and efficiency of immunohistochemistry procedures, thereby making it a preferred method for detailed tissue analysis. For instance, in May 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the worldwide commercial launch of a new world sales sorting instrument offering two breakthrough technologies that enable researchers to uncover more detailed information about sales that were previously invisible in traditional flow cytometry experiments. With BD CellView Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With BD SpectalFX Technology, researchers can achieve full spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high parameter experiments within a simplified workflow.

Rising Focus on Personalized Medicine

The increasing shift toward personalized medicine, especially in oncology, is driving the need for immunohistochemistry to identify specific molecular targets and tailor treatments to individual patient profiles, thus improving therapeutic outcomes. For instance, in June 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of Gibco OncoPro Tumor Roid Culture Medium Kit, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications. Similarly, in January 2023, Apollo Cancer Center, Bengaluru, launched India's first AI Precision Oncology Center (POC) in a significant move that will substantially enhance the quality of oncology care. The Center will help the oncologists, patients, and caregivers to arrive at the best possible results in a time-bound manner the enormous possibilities offered by AI. This is influencing the immunohistochemistry market revenue across the globe.

Immunohistochemistry Market Segmentation:

Breakup by Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Antibodies accounts for the majority of the market share

The increasing need for disease diagnosis and research, especially cancers and infectious diseases is elevating the demand for specific antibodies. The rising innovations in antibody engineering improve specificity and sensitivity, enhancing diagnostic accuracy. The expanding biomedical research necessitates diverse antibodies for detailed cellular and molecular studies. Personalized treatment approaches require precise biomarker identification, boosting the use of targeted antibodies. For instance, in August 2023, Regeneron Pharmaceuticals, Inc. announced that the Biomedical Advanced Research and Development (BARDA)authority has agreed with Regeneron to support clinical development, clinical manufacturing, and the regulatory licensure process of on next-generation COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection.

Breakup by Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Diagnostics holds the largest share of the industry

The increasing cases of cardiovascular, infectious diseases, cancer, autoimmune, nephrological conditions, and diabetes necessitate advanced diagnostic methods. In line with this, the enhancing focus on personalized treatment plans based on specific biomarkers detected through immunohistochemistry. Significant improvements in staining techniques and emerging technologies improve the accuracy and efficiency of disease diagnosis. The growing research activities require detailed cellular analysis, promoting the use of immunohistochemistry in understanding disease mechanisms and pathology. This is further driving the demand for diagnostics in the immunohistochemistry market growth.

Breakup by End-Use:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Hospitals and Diagnostic Laboratories represents the leading market segment

The rising rates of chronic diseases particularly cancers, are driving the demand for precise diagnostic tools such as immunohistochemistry to accurately identify and classify disease states. Significant innovations in digital imaging systems and staining techniques enhance the diagnostic capabilities and throughput of immunohistochemistry, making it more appealing for clinical settings. The rising focus on adherence to high quality and regulatory standards in diagnostic processes necessitates reliable techniques like immunohistochemistry. The increasing investments in healthcare infrastructure and diagnostic services boost the adoption of advanced diagnostic methods, such as immunohistochemistry, in both developed and emerging markets.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest immunohistochemistry market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for immunohistochemistry.

The rising cases of cancer and other chronic conditions are driving the demand for precise diagnostic methods like immunohistochemistry to identify biomarkers for effective treatment which is influencing the market growth across the region. The well-established healthcare facilities and robust funding research and development (R&D) are facilitating the adoption of advanced diagnostic technologies. According to the data from the National Library of Medicine, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The market is highly competitive, with key players like Agilent Technologies, Thermo Fisher Scientific, and Roche Diagnostics dominating. These players focus on innovation and strategic partnerships to enhance their product portfolios. Other significant companies such as Merk Group, Bio-Rad Laboratories, and Danaher Corporation, emphasize expanding their global footprints through collaborations and acquisitions. In February 2023, Agilent Technologies Inc. introduced an integrated solution that combines their xCELLigence RTCA HT platform with the Bio Tek BioSpa 8 Automated Incubator. This new development offers a higher level of workflow automation, allowing further creation of label-free high throughput potency assays for immune-oncology and high throughput viral cytopathic effects (CPE) assays for the vaccine market.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global immunohistochemistry market?
  • What is the impact of each driver, restraint, and opportunity on the global immunohistochemistry market?
  • What are the key regional markets?
  • Which countries represent the most attractive immunohistochemistry market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the immunohistochemistry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the immunohistochemistry market?
  • What is the breakup of the market based on the end-use?
  • Which is the most attractive end-use in the immunohistochemistry market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players